(-)[125I]pindolol binding to human peripheral lung beta-receptors

Area of Science:

• Pharmacology
• Biochemistry
• Pulmonary Medicine

Background:

• Beta-adrenergic receptors play a crucial role in regulating airway smooth muscle function.
• Accurate characterization of these receptors in human lung tissue is essential for understanding respiratory diseases and developing targeted therapies.

Purpose of the Study:

• To characterize beta-adrenergic receptors in human peripheral lung.
• To evaluate the utility of (-)[125I]pindolol as a radioligand for receptor quantification.
• To determine the subtype distribution of beta-adrenergic receptors in the human lung.

Main Methods:

• Radioligand binding assays using (-)[125I]pindolol.
• Biochemical assays measuring cyclic AMP production.
• Scatchard and kinetic analyses to determine receptor binding parameters (Kd, Bmax).
• Stereoselectivity and potency studies using various adrenergic agents.

Main Results:

• Specific binding of (-)[125I]pindolol reached equilibrium rapidly and was reversible.
• Kinetic, Scatchard, and computer analyses consistently indicated a single binding site for (-)[125I]pindolol.
• Mean dissociation constant (Kd) was 136 pM and mean receptor concentration was 118 fmol/mg protein across ten human lungs.
• Displacement studies confirmed stereoselectivity and expected potency for beta-receptor interactions.
• Isoproterenol stimulated cyclic AMP production, blocked by beta-antagonists.
• Approximately 70% of beta-receptors were identified as the beta 2-subtype.

Conclusions:

• (-)[125I]pindolol is a highly effective and reproducible radioligand for characterizing human lung beta-adrenergic receptors.
• The human lung predominantly expresses beta 2-adrenergic receptors.
• This methodology allows for accurate receptor quantification even with limited tissue samples.